These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7687129)

  • 1. An echistatin C-terminal peptide activates GPIIbIIIa binding to fibrinogen, fibronectin, vitronectin and collagen type I and type IV.
    Wright PS; Saudek V; Owen TJ; Harbeson SL; Bitonti AJ
    Biochem J; 1993 Jul; 293 ( Pt 1)(Pt 1):263-7. PubMed ID: 7687129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding of the snake venom-derived proteins applaggin and echistatin to the arginine-glycine-aspartic acid recognition site(s) on platelet glycoprotein IIb.IIIa complex inhibits receptor function.
    Savage B; Marzec UM; Chao BH; Harker LA; Maraganore JM; Ruggeri ZM
    J Biol Chem; 1990 Jul; 265(20):11766-72. PubMed ID: 2365698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The integrin alpha IIb beta 3 contains distinct and interacting binding sites for snake-venom RGD (Arg-Gly-Asp) proteins. Evidence that the receptor-binding characteristics of snake-venom RGD proteins are related to the amino acid environment flanking the sequence RGD.
    Rahman S; Lu X; Kakkar VV; Authi KS
    Biochem J; 1995 Nov; 312 ( Pt 1)(Pt 1):223-32. PubMed ID: 7492316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved potency and specificity of Arg-Gly-Asp (RGD) containing peptides as fibrinogen receptor blocking drugs.
    Foster MR; Hornby EJ; Brown S; Kitchin J; Hann M; Ward P
    Thromb Res; 1993 Nov; 72(3):231-45. PubMed ID: 8303662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of RGD loop and C-terminal domain of echistatin for recognition of alphaIIb beta3 and alpha(v) beta3 integrins and expression of ligand-induced binding site.
    Marcinkiewicz C; Vijay-Kumar S; McLane MA; Niewiarowski S
    Blood; 1997 Aug; 90(4):1565-75. PubMed ID: 9269775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amino acid sequences in fibrinogen mediating its interaction with its platelet receptor, GPIIbIIIa.
    Andrieux A; Hudry-Clergeon G; Ryckewaert JJ; Chapel A; Ginsberg MH; Plow EF; Marguerie G
    J Biol Chem; 1989 Jun; 264(16):9258-65. PubMed ID: 2722830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preferential antagonism of the interactions of the integrin alpha IIb beta 3 with immobilized glycoprotein ligands by snake-venom RGD (Arg-Gly-Asp) proteins. Evidence supporting a functional role for the amino acid residues flanking the tripeptide RGD in determining the inhibitory properties of snake-venom RGD proteins.
    Lu X; Williams JA; Deadman JJ; Salmon GP; Kakkar VV; Wilkinson JM; Baruch D; Authi KS; Rahman S
    Biochem J; 1994 Dec; 304 ( Pt 3)(Pt 3):929-36. PubMed ID: 7529494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A colourimetric enzyme-linked sandwich assay for the detection of human platelets bound to a fibrinogen-coated surface.
    Nieman CJ; Kerry R; Coleman PJ; Taylor A; Jose J; Pay GF
    Thromb Res; 1991 May; 62(3):189-97. PubMed ID: 1891764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta 3 integrin derived peptide 217-230 inhibits fibrinogen binding and platelet aggregation: significance of RGD sequences and fibrinogen A alpha-chain.
    Lasz EC; McLane MA; Trybulec M; Kowalska MA; Khan S; Budzynski AZ; Niewiarowski S
    Biochem Biophys Res Commun; 1993 Jan; 190(1):118-24. PubMed ID: 8422238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A model of platelet aggregation involving multiple interactions of thrombospondin-1, fibrinogen, and GPIIbIIIa receptor.
    Bonnefoy A; Hantgan R; Legrand C; Frojmovic MM
    J Biol Chem; 2001 Feb; 276(8):5605-12. PubMed ID: 11094060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the cross-linking site of disintegrins albolabrin, bitistatin, echistatin, and eristostatin on isolated human platelet integrin GPIIb/IIIa.
    Calvete JJ; McLane MA; Stewart GJ; Niewiarowski S
    Biochem Biophys Res Commun; 1994 Jul; 202(1):135-40. PubMed ID: 8037704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclic RGD peptide analogues as antiplatelet antithrombotics.
    Barker PL; Bullens S; Bunting S; Burdick DJ; Chan KS; Deisher T; Eigenbrot C; Gadek TR; Gantzos R; Lipari MT
    J Med Chem; 1992 May; 35(11):2040-8. PubMed ID: 1597855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of in vitro tumor cell invasion by Arg-Gly-Asp-containing synthetic peptides.
    Gehlsen KR; Argraves WS; Pierschbacher MD; Ruoslahti E
    J Cell Biol; 1988 Mar; 106(3):925-30. PubMed ID: 2450101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of RGD sequence motifs regulates disintegrin recognition of alphaIIb beta3 and alpha5 beta1 integrin complexes. Replacement of elegantin alanine-50 with proline, N-terminal to the RGD sequence, diminishes recognition of the alpha5 beta1 complex with restoration induced by Mn2+ cation.
    Rahman S; Aitken A; Flynn G; Formstone C; Savidge GF
    Biochem J; 1998 Oct; 335 ( Pt 2)(Pt 2):247-57. PubMed ID: 9761721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel effect of cyclicization of the Arg-Gly-Asp-containing peptide on vitronectin binding to platelets.
    Mohri H; Hashimoto Y; Ohba M; Kumagai H; Ohkubo T
    Am J Hematol; 1991 May; 37(1):14-9. PubMed ID: 1708943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A potent antiplatelet peptide, triflavin, from Trimeresurus flavoviridis snake venom.
    Huang TF; Sheu JR; Teng CM
    Biochem J; 1991 Jul; 277 ( Pt 2)(Pt 2):351-7. PubMed ID: 1859363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemical synthesis of echistatin, a potent inhibitor of platelet aggregation from Echis carinatus: synthesis and biological activity of selected analogs.
    Garsky VM; Lumma PK; Freidinger RM; Pitzenberger SM; Randall WC; Veber DF; Gould RJ; Friedman PA
    Proc Natl Acad Sci U S A; 1989 Jun; 86(11):4022-6. PubMed ID: 2726764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of integrin-mediated platelet aggregation, fibrinogen-binding, and interactions with extracellular matrix by nonpeptidic mimetics of Arg-Gly-Asp.
    Varon D; Lider O; Dardik R; Shenkman B; Alon R; Hershkoviz R; Kapustina G; Savion N; Martinowitz U; Greenspoon N
    Thromb Haemost; 1993 Dec; 70(6):1030-6. PubMed ID: 8165596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on alpha v beta 3/ligand interactions using a [3H]SK&F-107260 binding assay.
    Wong A; Hwang SM; McDevitt P; McNulty D; Stadel JM; Johanson K
    Mol Pharmacol; 1996 Sep; 50(3):529-37. PubMed ID: 8794891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Echistatin. A potent platelet aggregation inhibitor from the venom of the viper, Echis carinatus.
    Gan ZR; Gould RJ; Jacobs JW; Friedman PA; Polokoff MA
    J Biol Chem; 1988 Dec; 263(36):19827-32. PubMed ID: 3198653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.